Azido-PEG6-NHS ester is a heterobifunctional polyethylene glycol linker featuring a terminal azide group for bioorthogonal conjugation and an N-hydroxysuccinimide (NHS) ester for efficient acylation of primary amines on proteins, peptides, or amine-functionalized ligands. The PEG6 chain provides a flexible, hydrophilic spacer that helps reduce steric hindrance and improves accessibility of the reactive termini, which is particularly important when assembling PROTACs or related targeted degradation constructs. In PROTAC design workflows, this linker enables modular coupling: the NHS ester can first be used to attach to an amine-bearing targeting moiety or handle, and the resulting azide functionality can then be used for subsequent conjugation via copper-free or copper-catalyzed azide–alkyne cycloaddition (“click”) to connect to the complementary component. Its practical value lies in facilitating stepwise synthesis, improving conjugation efficiency, and supporting the generation of well-defined, multi-component degraders for structure–activity and mechanistic studies.
Structure of 2055014-64-5
* For research and manufacturing use only. Not for human or clinical use.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
| ConcentrationVolumeMass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 2.0987 mL | 10.4936 mL | 20.9872 mL |
| 5 mM | 0.4197 mL | 2.0987 mL | 4.1974 mL |
| 10 mM | 0.2099 mL | 1.0494 mL | 2.0987 mL |
Azido-PEG6-NHS ester is a bifunctional polyethylene glycol linker designed for constructing PROTACs and related targeted protein degradation conjugates. It couples an NHS-activated ester for efficient amide-bond formation with an azide handle for subsequent bioorthogonal ligation, enabling modular assembly of ternary or multicomponent degraders. Its PEG-based spacer improves aqueous compatibility and can help tune linker flexibility, while orthogonal reactivity supports sequential, controlled conjugation workflows. Detailed structural and reactivity considerations are provided below.
Structure: The molecule contains a PEG-based hydrophilic chain terminating in an NHS ester and a terminal azide group. It features an activated carboxylate for nucleophilic acyl substitution and an azide functionality suitable for click-type transformations. The ether-rich backbone confers flexibility and improved solubility in aqueous media.
Reactivity: The NHS ester reacts with primary amines to form stable amide bonds via nucleophilic acyl substitution, typically under mildly basic conditions in aqueous or mixed aqueous/organic solvents. The azide group is commonly preserved for orthogonal conjugation, including copper-catalyzed azide–alkyne cycloaddition or strain-promoted azide–alkyne cycloaddition, depending on the partner and desired biocompatibility. To maintain reactivity, avoid strong nucleophiles that can hydrolyze the NHS ester and minimize prolonged exposure to water before coupling.
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
Please contact us with any specific requirements and we will get back to you as soon as possible.